Andere Sprachen Anixa Biosciences, Inc.

Aktien

A2N6ZF

US03528H1095

ANIX

Realtime-Estimate Cboe BZX Andere Börsenplätze 16:42:41 04.06.2024			% 5 Tage	% 1. Jan.
2,54 ^USD	-1,17 %		+4,03 %	-33,51 %

21.05.	Anixa Biosciences, Inc. beginnt mit der Behandlung der fünften Patientin in der klinischen CAR-T-Studie zu Eierstockkrebs	CI
08.05.	Anixa Biosciences, Inc. schließt ein gemeinsames Entwicklungsabkommen mit der Cleveland Clinic zur Entwicklung neuartiger Impfstoffe für verschiedene Krebsarten	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial	21.05.
Anixa Biosciences, Inc. Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial	21.05.
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines	08.05.
Anixa Biosciences, Inc. Enters into a Joint Development Agreement with Cleveland Clinic to Develop Novel Vaccines for Various Cancer Types	08.05.
Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja	06.05.
Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 and 9, 2024	01.05.
Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024	30.04.
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board	19.04.
Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board	18.04.
InvestorBrandMedia: Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth	20.03.
Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties	14.03.
Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	12.03.
Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress	11.03.
Anixa Biosciences Initiates Higher Dosing in Phase 1 Study of Ovarian Cancer Treatment	12.02.
Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial	12.02.
Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference	29.01.
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology	24.01.
Anixa Biosciences Says Japan Grants Patent to Ovarian Cancer Vaccine Technology	23.01.
Anixa Biosciences, Inc. Announces Japanese Patent on Ovarian Cancer Vaccine Technology	23.01.
North American Morning Briefing : Stock Futures Steady as Earnings Season Ramps Up	23.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Anixa Biosciences, Inc.

Aktien

A2N6ZF

US03528H1095

ANIX

Andere Sprachen

Filter